Straumann® TLX Implant System

Iconic Tissue Level meets Immediacy.

The design of the Straumann® TLX Implant takes into account key biological principles of hard and soft tissue healing.

Designed for immediate protocols

Fully tapered implant design for optimized primary stability combined with the predictability of Tissue Level Implant. A narrow implant diameter option, 3.75 mm for all indications

Peri-implant health-preservation

Reduced risk of nesting bacteria. Optimized cleansability with the connection at the soft-tissue level. Immediate soft-tissue attachment preservation

Simplicity and efficiency

A one-stage process with restoration at soft-tissue level allows you to use chair time more efficiently. Ease of restoration even in the posterior region. Highly efficient treatment protocol thanks to straightforward conventional and digitally integrated workflows

Dynamic bone management

Redistribution of native bone and control over insertion torque

Real confidence

Swiss precision and quality with Roxolid® material and SLActive® surface

Featured stories on youTooth

Brochures and videos

Looking for additional information? You'll find them in the Resource Center.

Contact us

Name*

E-mail*

Location*

Your message*

Data usage agreement*

I acknowledge that my data will be processed according to the terms and conditions of the privacy notice.

Read our privacy notice.

Captcha*

Please retype the code above

References

1 Ioannidis A, Gallucci GO, Jung RE, Borzangy S, Hämmerle CH, Benic GI. Titanium-zirconium narrow-diameter versus titanium regulardiameter implants for anterior and premolar single crowns: 3-year results of a randomized controlled clinical study. J Clin Periodontol. 2015 Nov;42(11):1060-70. doi: 10.1111/jcpe.12468. Epub 2015 Nov 14.
2 Al-Nawas B, Domagala P, Fragola G, Freiberger P, Ortiz- Vigón A, Rousseau P, Tondela J. A Prospective Noninterventional Study to Evaluate Survival and Success of Reduced Diameter Implants Made From Titanium-Zirconium Alloy. J Oral Implantol. 2015 Aug;41(4):e118-25. doi: 10.1563/ AAID-JOI-D-13-00149. Epub 2014 Mar 25.
3 Altuna P, Lucas-Taulé E, Gargallo-Albiol J, Figueras-Álvarez O, Hernández-Alfaro F, Nart J. Clinical evidence on titanium-zirconium dental implants: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2016 Jul;45(7):842-50. doi: 10.1016/j.ijom.2016.01.004. Epub 2016 Feb 3.
4 Nicolau P, Guerra F, Reis R, Krafft T, Benz K , Jackowski J 10-year results from a randomized controlled multicenter study with immediately and early loaded SLActive implants in posterior jaws. Presented at 25th Annual Scientific Meeting of the European Association of Osseointegration – 29 Sep – 1 Oct 2016, Paris.
5 Nelson, K., Stricker, A., Raguse, J.-D. and Nahles, S. (2016), Rehabilitation of irradiated patients with chemically modified and conventional SLA implants: a clinical clarification. J Oral Rehabil, 43: 871–872. doi:10.1111/joor.12434.
6 Patients treated with dental implants after surgery and radio-chemotherapy of oral cancer. Heberer S, Kilic S, Hossamo J, Raguse J-D, Nelson K. Rehabilitation of irradiated patients with modified and conventional sandblasted, acid-etched implants: preliminary results of a split-mouth study. Clin. Oral Impl. Res. 22, 2011; 546–551.
7 Straumann (2016). SLActive® supports enhanced bone formation in a minipig surgical GBR model with coronal circumferential defects. Unpublished data.
8 Norm ASTM F67 (states min. tensile strength of annealed titanium); data on file for Straumann cold-worked titanium and Roxolid® implants.
9 Maniura K. Laboratory for Materials – Biology Interactions Empa, St. Gallen, Switzerland. Protein and blood adsorption on Ti and TiZr implants as a model for osseointegration. EAO 22nd Annual Scientific Meeting; October 17–19; 2013; Dublin.